These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

702 related items for PubMed ID: 16513871

  • 1. Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.
    Artaloytia JF, Arango C, Lahti A, Sanz J, Pascual A, Cubero P, Prieto D, Palomo T.
    Am J Psychiatry; 2006 Mar; 163(3):488-93. PubMed ID: 16513871
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.
    Marder SR, Davis JM, Chouinard G.
    J Clin Psychiatry; 1997 Dec; 58(12):538-46. PubMed ID: 9448657
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
    Zimbroff DL, Kane JM, Tamminga CA, Daniel DG, Mack RJ, Wozniak PJ, Sebree TB, Wallin BA, Kashkin KB.
    Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Risperidone and olanzapine versus another first generation antipsychotic in patients with schizophrenia inadequately responsive to first generation antipsychotics.
    Chen JJ, Chan HY, Chen CH, Gau SS, Hwu HG.
    Pharmacopsychiatry; 2012 Mar; 45(2):64-71. PubMed ID: 22086749
    [Abstract] [Full Text] [Related]

  • 13. Treatment of the symptoms of schizophrenia: a combined analysis of double-blind studies comparing risperidone with haloperidol and other antipsychotic agents.
    Glick ID, Lemmens P, Vester-Blokland E.
    Int Clin Psychopharmacol; 2001 Sep; 16(5):265-74. PubMed ID: 11552769
    [Abstract] [Full Text] [Related]

  • 14. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine.
    Tollefson GD, Sanger TM.
    Am J Psychiatry; 1997 Apr; 154(4):466-74. PubMed ID: 9090332
    [Abstract] [Full Text] [Related]

  • 15. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
    Azorin JM, Spiegel R, Remington G, Vanelle JM, Péré JJ, Giguere M, Bourdeix I.
    Am J Psychiatry; 2001 Aug; 158(8):1305-13. PubMed ID: 11481167
    [Abstract] [Full Text] [Related]

  • 16. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.
    Breier AF, Malhotra AK, Su TP, Pinals DA, Elman I, Adler CM, Lafargue RT, Clifton A, Pickar D.
    Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Josiassen RC, Joseph A, Kohegyi E, Stokes S, Dadvand M, Paing WW, Shaughnessy RA.
    Am J Psychiatry; 2005 Jan; 162(1):130-6. PubMed ID: 15625211
    [Abstract] [Full Text] [Related]

  • 19. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L, Arnott W.
    J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
    [Abstract] [Full Text] [Related]

  • 20. Risperidone versus haloperidol in psychotic patients with disturbing neuroleptic-induced extrapyramidal symptoms: a double-blind, multi-center trial.
    Heck AH, Haffmans PM, de Groot IW, Hoencamp E.
    Schizophr Res; 2000 Dec 15; 46(2-3):97-105. PubMed ID: 11120421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.